Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CALM1 | P0DP23 | 2/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | NQO2 | P16083 | 1/20 | 0.39 |
| ▸ | CRHR1 | P34998 | 1/20 | 0.39 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.38 |
| ▸ | TUBB | P07437 | 1/20 | 0.38 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.38 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.38 |
| ▸ | TUBA4A | P68366 | 1/20 | 0.38 |
| ▸ | TUBB4B | P68371 | 1/20 | 0.38 |
| ▸ | TUBB3 | Q13509 | 1/20 | 0.38 |
| ▸ | TUBB2A | Q13885 | 1/20 | 0.38 |
| ▸ | TUBB8 | Q3ZCM7 | 1/20 | 0.38 |
| ▸ | TUBA3E | Q6PEY2 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20354546 | 0.81 | PDGFRB (0.48) | CALM1CYP3A4TSHRMEN1LMNA | |
| SCHEMBL21614179 | 0.81 | PTPN1 (0.38) | TSHRALDH1A1TDP1 | |
| SCHEMBL2096172 | 0.78 | ALDH1A1 (0.50) | CALM1CYP3A4CYP1A2CA2ALDH1A1 | |
| SCHEMBL21614175 | 0.78 | HTR2A (0.38) | CALM1CYP3A4TSHRMEN1LMNA | |
| SCHEMBL21553367 | 0.77 | ADK (0.43) | CALM1CYP3A4TSHRMEN1LMNA | |
| SCHEMBL21553366 | 0.77 | TUBB1 (0.71) | TSHRMEN1KMT2ANQO2TUBB4A | |
| SCHEMBL14609613 | 0.76 | TUBB4A (0.58) | CYP3A4LMNACYP1A2TUBB4ATUBB | |
| SCHEMBL12671987 | 0.76 | NQO2 (0.41) | CALM1CYP3A4TSHRMEN1LMNA | |
| SCHEMBL20339017 | 0.75 | CA12 (0.38) | CALM1CYP3A4TSHRMEN1LMNA | |
| SCHEMBL28979980 | 0.74 | NQO2 (0.40) | CALM1CYP3A4TSHRMEN1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3562817-B1 | ORGANIC MATERIALS WITH SPECIAL OPTICAL EFFECTS | CENTRE NAT RECH SCIENT (FR) | 2023-11-15 | — | — | EP | disclosed |
| EP-3562817-B1 | ORGANIC MATERIALS WITH SPECIAL OPTICAL EFFECTS | CENTRE NAT RECH SCIENT (FR) | 2023-11-15 | — | — | EP | disclosed |
| US-11613513-B2 | Organic materials with special optical effects | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 2023-03-28 | — | — | US | disclosed |
| US-20190337885-A1 | Organic Materials with Special Optical Effects | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 2019-11-07 | — | — | US | disclosed |
| US-20190337885-A1 | Organic Materials with Special Optical Effects | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 2019-11-07 | — | — | US | disclosed |
| WO-2018122359-A1 | ORGANIC MATERIALS WITH SPECIAL OPTICAL EFFECTS | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 2018-07-05 | — | — | WO | disclosed |
| US-20160193329-A1 | Deletion Mutants of Flagellin and Methods of Use | VAXINNATE CORPORATION | 2016-07-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190337885-A1 | Organic Materials with Special Optical Effects | IK, TYR, MITF | CALM1 1657/4885CYP3A4 801/4885TSHR 4390/4885 |
| US-11613513-B2 | Organic materials with special optical effects | IK, TYR, MITF | CALM1 1657/4885CYP3A4 801/4885TSHR 4390/4885 |
| US-20160193329-A1 | Deletion Mutants of Flagellin and Methods of Use | MYD88, IFNG, NOD2 | CALM1 1131/4885CYP3A4 4871/4885TSHR 3399/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.